At a glance
ClinicalIndex Comparison RecordN/ACompleted· 43 enrolled
Drug / intervention
Fixed Lingual Mandibular Growth Modificator (FLMGM)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Controlled Evaluation of Class II Division 1 Malocclusions Treated With Fixed Lingual Mandibular Growth Modificator (FLMGM)
In Brief
A clinical study evaluating Fixed Lingual Mandibular Growth Modificator (FLMGM) for Class II Division 1 Malocclusion and Retrognathic Mandible. Completed, enrolled 43 participants across 1 site.
Detailed Summary
The current trial was designed to investigate the possible initial net skeletal and dental effects of treatment with FLMGM by a comparative evaluation of treated and untreated Cl II/1 malocclusion subjects. The null hypothesis stated that there were no significant differences in dentofacial changes between FLMGM group and control group.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSyria
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2009
Primary CompletionJul 2011
Study CompletionDec 2012
First PostedMay 2013
TodayJul 2026
First PostedMay 14, 2013
Enrollment StartMay 1, 2009
Primary CompletionJul 1, 2011
Study CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 13.1 years ago
Interventions
Fixed Lingual Mandibular Growth Modificator (FLMGM)device
Novel Class II functional appliance, a fixed version of double-plate appliance